Table 1: Baseline demographics and clinical characteristics, patients and caregivers.

 

T1D PWD

N = 100

T1D CG*

N = 100

T2D MTI

N = 100

T2D BI

N = 100

Age, Caregivers, %1

 

 

 

 

18 - < 40 years

19

20

9

12

≥ 40 - ≤ 65 years

81

80

91

88

Age, Child2

 

 

 

 

1-5 years

-

9

-

-

6-11 years

-

42

-

-

12-17 years

-

49

-

-

Female, % (Adults)1

43

58

38

42

Prefer not to answer

-

6

-

1

Relationship to Child with T1D, %1

 

 

 

 

Parent

-

84

-

-

Aunt/Uncle

-

10

-

-

Grandparent

-

5

-

-

Other Family Member

-

1

-

-

Type of Diabetes Therapy, %2

 

 

 

 

Oral therapy

32

61

-

1

Basal insulin

59

43

30

99

Meal-time insulin

64

38

100

2

Other

2

8

3

3

Concomitant Chronic Health Conditions %

(excluding diabetes)2

 

 

 

 

Arthritis

12

8

24

32

Alzheimer's disease

3

4

3

2

Asthma

17

13

21

18

Cardiovascular disease

7

4

8

12

Depression

21

17

36

36

Heart disease

9

5

12

16

Osteoporosis

3

3

3

5

Other

4

1

7

3

% of Patients on insulin who experienced blood sugar levels < 54 mg/dL combined with one or more symptoms of severe hypoglycemia in the

last 12 months**

95

96

90

86

Traditional Glucagon Kits Ever Purchased/Owned, %

 

 

 

 

Glucagon Emergency Kit (Lilly)

54

61

21

28

Glucagen HypoKit (Novo)

34

52

24

30

Glucagon Emergency Kit (Fresenius)

45

41

23

23

None

13

6

49

40

T1D PWD: Adult Type 1 patients; T1D CG: Caregivers of pediatric Type 1 patients; T2D MTI: Adult Type 2 patients on meal-time insulin; T2D BI: Adult Type 2 patients on basal insulin (but not meal-time insulin. 1Among caregivers. 2Among patients *Reported by caregiver on behalf of child, **Self-reported